AbilityPharma AbilityPharma (also known as Ability Pharmaceuticals) is a biopharmaceutical company developing drugs targeting cancer. | PDS Biotechnology PDS Biotechnology is a biopharmaceutical company focused on the development and commercialization of therapies based on the versamune platform. | ImmunoPhotonics Immunophotonics is a biotechnology company developing a proprietary carbohydrate polymer. | |||
Founding Date | Founding Date 2009 | Founding Date 2005 | Founding Date 1997 | Founding Date 2003 | Founding Date 2008 |
Type | Type Private | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Barcelona, ES HQ Cerdanyola Del Vallès, ES | Locations Princeton, US HQ Florham Park, US | Locations Planegg, DE HQ | Locations Modi'in-Maccabim-Re'ut, IL HQ | Locations St. Louis, US HQ |
Employees | Employees 23 | Employees 317% increase | Employees 13 | Employees 2414% decrease | Employees 18 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 74 m | Valuation ($) 38.5 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €336k (FY, 2024) | Revenue (est.) $1.2m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods €84k (FY, 2024) | Cost of goods $230k (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit €261k (FY, 2024) | Gross profit $950k (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income ($34.5m) (FY, 2025) | Net income (€8.3m) (FY, 2024) | Net income ($2m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 2m | Total funding raised N/A | Total funding raised $ 100.9m | Total funding raised $ 3.1m |
PDS Biotechnology is a biopharmaceutical company focused on the development and commercialization of therapies based on the versamune platform.
View company
4SC is a biopharmaceutical company developing small-molecule drugs for the treatment of cancer.
View company
BioLineRx is a biopharmaceutical company focused on oncology.
View companyImmunophotonics is a biotechnology company developing a proprietary carbohydrate polymer.
View company